Alkermes | Results Presentation Deck | 15 slides

Alkermes · 2021-02
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 10 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits
0/1 slides
0/1 slides
0/1 slides
100% 1/1 slides
0/1 slides
Financials 4 slides 100% 4/4 slides 100% 4/4 slides · 18 hits
0/4 slides
0/4 slides
0/4 slides
100% 4/4 slides
0/4 slides
Product Performance 3 slides 100% 3/3 slides 100% 3/3 slides · 14 hits
0/3 slides
0/3 slides
0/3 slides
100% 3/3 slides 100% 3/3 slides Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits
0/2 slides
0/2 slides
50% 1/2 slides 100% 2/2 slides
0/2 slides

Slide inventory

15
every slide · same image gating as the playbook
01
Slide 1
front_matter
02
front_matter
03
front_matter
04
The slide uses a three-column layout to categorize accomplishments.summarize
Open slide detailBeat · Problem
05
Uses a numbered process-style chevron layout to organize strategic priorities.present_framework
Open slide detailLoop · Cost Of Inaction
06
The slide uses red dashed boxes to highlight specific adjustments related to a $150M milestone payment from Biogen.analyze_data
Open slide detailBeat · Financials
07
The table highlights Q4 2020 performance with a green border around the Q4 2020 column.analyze_data
Open slide detailBeat · Financials
08
Includes footnotes explaining specific revenue fluctuations due to COVID-19 and milestone payments.analyze_data
Open slide detailBeat · Financials
09
Includes GAAP and non-GAAP metrics with detailed footnotes regarding assumptions and reconciliation.analyze_data
Open slide detailBeat · Financials
10
Includes a disclaimer regarding forward-looking statements at the bottom.analyze_data
Open slide detailBeat · Product PerformanceLoop · Voice Of Customer
11
Includes disclaimer regarding forward-looking statements and COVID-19 impact.analyze_data
Open slide detailBeat · Product PerformanceLoop · Voice Of Customer
12
The chart includes a vertical dashed line between Q4'19 and Q1'20, likely indicating a fiscal or calendar year transition.analyze_data
Open slide detailBeat · Product PerformanceLoop · Voice Of Customer
13
Slide 13 of an Alkermes presentation.present_solution
Open slide detailBeat · Solution
14
The slide uses a sequential process flow to describe the clinical development strategy.plan_implementation
Open slide detailBeat · Solution
15
state_next_steps